CSPC Pharmaceutical Group Limited (CVG) — Capital Reinvestment Ratio
CSPC Pharmaceutical Group Limited (CVG) has a Capital Reinvestment Ratio of 0.12x as of September 2020, meaning it reinvests 0% of its operating cash flow (€2.16 Billion) in capital expenditures (€258.14 Million). Check CSPC Pharmaceutical Group Limited tangible book value ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
CSPC Pharmaceutical Group Limited Capital Reinvestment Ratio (2013–2025)
This chart tracks CSPC Pharmaceutical Group Limited's Capital Reinvestment Ratio across 13 annual periods. For the full cash flow conversion analysis, see CVG cash flow conversion.
Annual Capital Reinvestment Ratio for CSPC Pharmaceutical Group Limited (2013–2025)
Year-by-year Capital Reinvestment Ratio for CSPC Pharmaceutical Group Limited from 2013 to 2025. See cash generation quality of CSPC Pharmaceutical Group Limited to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.39x | €5.83 Billion | €2.28 Billion | ▼ -33.8% |
| 2024 | 0.59x | €4.53 Billion | €2.68 Billion | ▲ +30.4% |
| 2023 | 0.45x | €4.18 Billion | €1.89 Billion | ▲ +55.6% |
| 2022 | 0.29x | €7.63 Billion | €2.22 Billion | ▼ -4.3% |
| 2021 | 0.30x | €4.64 Billion | €1.41 Billion | ▲ +51.1% |
| 2020 | 0.20x | €6.74 Billion | €1.36 Billion | ▼ -59.6% |
| 2019 | 0.50x | €3.78 Billion | €1.88 Billion | ▲ +13.3% |
| 2018 | 0.44x | €3.80 Billion | €1.67 Billion | ▲ +22.6% |
| 2017 | 0.36x | €3.29 Billion | €1.18 Billion | ▼ -1.7% |
| 2016 | 0.36x | €2.92 Billion | €1.06 Billion | ▲ +0.4% |
| 2015 | 0.36x | €2.25 Billion | €815.69 Million | ▼ -18.8% |
| 2014 | 0.45x | €1.81 Billion | €807.00 Million | ▼ -39.0% |
| 2013 | 0.73x | €814.86 Million | €597.12 Million | — |